Inari, Stryker

Stryker agrees to acquire Inari Medical for $4.9bn
Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock for $80 per share in cash, which equates to a total equity value of nearly $4.9bn. Inari is poised to enhance Stryker's footprint in the peripheral vascular sector, particularly in the venous thromboembolism (VTE) market.
Stryker Buying Inari Medical in $4.9B Deal to Boost Vascular Business
Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an approximate value of $4.9 billion.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker confirms deal to purchase Inari Medical for $80 a share
Stryker announces agreement to acquire Inari Medical for $4.9 billion, resulting in a 21% jump in Inari's shares.
Device maker Stryker strikes $4.9 billion deal for Inari Medical
By Anirban Sen NEW YORK (Reuters) -Medical-device maker Stryker on Monday agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion.
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal
Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news.
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.
Inari Medical soars on report of Stryker talks
Inari Medical's stock surged 6% amid reports of advanced acquisition talks with Stryker, potentially closing a deal this week.
Stryker to acquire Inari Medical for $4.9B
Stryker said its planned acquisition of Inari Medical would strengthen its position in the peripheral vascular market.
Stryker strikes $4.9B deal to buy Inari Medical
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.
Stryker’s Strategic Acquisition of Inari Medical Announced
Stryker ( (SYK) ) has provided an announcement.Stay Ahead of the Market:Discover outperforming stocks and invest smarter with Top Smart Score
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Key Takeaways Shares of Inari Medical surged Monday afternoon and again Tuesday morning as reports of an imminent acquisition ...
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...